Page last updated: 2024-11-04

spiperone and Nerve Degeneration

spiperone has been researched along with Nerve Degeneration in 7 studies

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnati, LF1
Fuxe, K1
Calza, L1
Benfenati, F1
Cavicchioli, L1
Toffano, G1
Goldstein, M1
Bardgett, ME1
Jackson, JL1
Taylor, GT1
Csernansky, JG1
Volkow, ND1
Wang, GJ1
Fowler, JS1
Logan, J1
Gatley, SJ1
MacGregor, RR1
Schlyer, DJ1
Hitzemann, R1
Wolf, AP1
Gallagher, IM1
Jenner, P1
Glover, V1
Clow, A1
Araujo, DM1
Cherry, SR1
Tatsukawa, KJ1
Toyokuni, T1
Kornblum, HI1
Ben-Shachar, D1
Pinhassi, B1
Youdim, MB1
Ruberg, M1
Javoy-Agid, F1
Hirsch, E1
Scatton, B1
LHeureux, R1
Hauw, JJ1
Duyckaerts, C1
Gray, F1
Morel-Maroger, A1
Rascol, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults[NCT03512171]Phase 165 participants (Actual)Interventional2016-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

7 other studies available for spiperone and Nerve Degeneration

ArticleYear
Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
    Acta physiologica Scandinavica, 1983, Volume: 119, Issue:4

    Topics: Animals; Cell Survival; Dendrites; G(M1) Ganglioside; Gangliosides; Male; Nerve Degeneration; Nerve

1983
Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia.
    Behavioural brain research, 1995, Volume: 70, Issue:2

    Topics: Animals; Brain Mapping; Caudate Nucleus; Cell Count; Disease Models, Animal; Dose-Response Relations

1995
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
    Psychiatry research, 1996, May-31, Volume: 67, Issue:1

    Topics: Adult; Age Factors; Aged; Aging; Cerebellum; Corpus Striatum; Dopamine Agonists; Female; Humans; Lig

1996
CuZn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and 3H-mazindol and 3H-spiperone binding over 19 months.
    Neuroscience letters, 2000, Aug-11, Volume: 289, Issue:3

    Topics: Animals; Binding Sites; Longevity; Male; Mazindol; Mice; Mice, Transgenic; Motor Activity; Neostriat

2000
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Experimental neurology, 2000, Volume: 166, Issue:2

    Topics: Animals; Autoradiography; Benzazepines; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine A

2000
Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    European journal of pharmacology, 1991, Sep-17, Volume: 202, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpr

1991
Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Annals of neurology, 1985, Volume: 18, Issue:5

    Topics: Aged; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Fema

1985